The market is segmented based on Segmentation, By Unit (Blood Components, Whole Blood), Articles (Instruments, Blood Processing Devices, Blood Transfusion Devices, Blood Culture Screening Devices, Diagnostic and Testing Instruments, Blood Storage Devices, Accessories, Syringes and Needles, Vials and Tubes, Blood Bank and Transfusion Software, Software, Assay Kits, Slide Staining, Blood Typing Reagents, Culture Media, Reagents and Kits, Blood Bags), End User (Hospitals, Blood Banks) – Industry Trends and Forecast to 2032
.
The Global Patient Blood Management Market size was valued at USD 15.12 USD Billion in 2024.
The Global Patient Blood Management Market is projected to grow at a CAGR of 7.8% during the forecast period of 2025 to 2032.
The major players operating in the market include Haemonetics Corporation ,Fresenius SE &, Co. KGaA ,Terumo Corporation ,ImmucorInc. , B Barun Melsungen AG , Maco Pharma ,bioMé,rieux ,KANEKA CORPORATION ,Bio-Rad Laboratories Inc. ,Abbott ,GrifolsS.A. ,F. Hoffmann-La Roche Ltd ,LivaNova PLC .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.